Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lactobacillus Reuteri ATCC PTA 4659 in Patients With Ulcerative Colitis

NCT03798210 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT03798210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03798210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lactobacillus Reuteri ATCC PTA 4659 in Patients With Ulcerative Colitis
Lead sponsor
Uppsala University
Phase
Phase 2
Overall status
Unknown status
Start date
January 1, 2017
Completion date
March 1, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis flare